Aims: Fabry disease is a rare but important cause of end-stage renal diseas
e. Recent molecular investigations on alpha -galactosidase A (alpha -Gal A)
have proven the existence of atypical variants in Fabry disease, making ge
notype assessment of each phenotype indispensable. We report here a missens
e mutation, which causes a typical form of Fabry disease. Material and meth
ods: The proband, a 45-year-old man, presented with acroparesthesias, hypoh
idrosis, left ventricular hypertrophy, renal involvement (proteinuria and r
enal insufficiency) with typical microscopic findings and extremely reduced
plasma alpha -Gal A activity, indicating the typical form of the disease.
Total RNA was isolated from the proband's cultured fibroblasts, reverse-tra
nscribed and amplified for direct sequencing of alpha -Gal A. Genomic. DNA
of the proband's mother and 75 controls (50 males and 25 females) living in
the same area as the proband was also examined. Results: Sequencing of the
cDNA revealed a substitution of G to A in codon 156 of alpha -GalA, result
ing in a single amino acid change from alanine to threonine (A156T). The mu
tation can be detected with PCR-RFLP with SfaNI digestion. This technique r
evealed that the mother was a heterozygote of A156T with no A156T noted in
the 100 haplotypes of the controls. With a vigorous search of the same muta
tion in the literature, no previous description was found other than one ca
se listed in several review papers as a classic phenotype without any other
information. In our study, we examined A156T in a pedigree and demonstrate
d that the mutation was not a polymorphic variant in our area. Conclusion:
Taken together, the present results strongly suggest that the missense muta
tion A156T, in the alpha -Gal A gene causes typical Fabry disease.